XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Market Offering
Common Stock
Common Stock
Market Offering
Additional Paid-in Capital
Additional Paid-in Capital
Market Offering
Accumulated Deficit
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2023     39,107,048        
Stockholders' equity, beginning balance at Dec. 31, 2023 $ 111,374   $ 4   $ 455,443   $ (344,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from at the market offering, net of issuance costs (in shares)       4,169,324      
Issuance of common stock from at the market offering, net of issuance costs   $ 20,089       $ 20,089  
Stock-based compensation expense 2,305       2,305    
Stock option exercises (in shares)     5,999        
Stock option exercises 12       12    
Net loss (16,193)           (16,193)
Stockholders' equity, ending balance (in shares) at Mar. 31, 2024     43,282,371        
Stockholders' equity, ending balance at Mar. 31, 2024 117,587   $ 4   477,849   (360,266)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2023     39,107,048        
Stockholders' equity, beginning balance at Dec. 31, 2023 111,374   $ 4   455,443   (344,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (50,115)            
Stockholders' equity, ending balance (in shares) at Sep. 30, 2024     43,721,772        
Stockholders' equity, ending balance at Sep. 30, 2024 89,379   $ 4   483,563   (394,188)
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2024     43,282,371        
Stockholders' equity, beginning balance at Mar. 31, 2024 117,587   $ 4   477,849   (360,266)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from at the market offering, net of issuance costs (in shares)     246,680 172,996      
Issuance of common stock from at the market offering, net of issuance costs 76 1,002     76 1,002  
Stock-based compensation expense 2,602       2,602    
Stock option exercises (in shares)     100        
Stock option exercises 0            
Net loss (17,249)           (17,249)
Stockholders' equity, ending balance (in shares) at Jun. 30, 2024     43,702,147        
Stockholders' equity, ending balance at Jun. 30, 2024 104,018   $ 4   481,529   (377,515)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from at the market offering, net of issuance costs (in shares)       8,500      
Stock-based compensation expense 2,011       2,011    
Stock option exercises (in shares)     11,125        
Stock option exercises 23       23    
Net loss (16,673)           (16,673)
Stockholders' equity, ending balance (in shares) at Sep. 30, 2024     43,721,772        
Stockholders' equity, ending balance at Sep. 30, 2024 $ 89,379   $ 4   483,563   (394,188)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2024 44,827,159   44,827,159        
Stockholders' equity, beginning balance at Dec. 31, 2024 $ 73,390   $ 5   487,973   (414,588)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 2,006       2,006    
Net loss (18,089)           (18,089)
Stockholders' equity, ending balance (in shares) at Mar. 31, 2025     44,827,159        
Stockholders' equity, ending balance at Mar. 31, 2025 $ 57,307   $ 5   489,979   (432,677)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2024 44,827,159   44,827,159        
Stockholders' equity, beginning balance at Dec. 31, 2024 $ 73,390   $ 5   487,973   (414,588)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock option exercises (in shares) 0            
Net loss $ (52,441)            
Stockholders' equity, ending balance (in shares) at Sep. 30, 2025 47,273,685   47,273,685        
Stockholders' equity, ending balance at Sep. 30, 2025 $ 29,614   $ 5   496,638   (467,029)
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2025     44,827,159        
Stockholders' equity, beginning balance at Mar. 31, 2025 57,307   $ 5   489,979   (432,677)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from at the market offering, net of issuance costs (in shares)     86,340 421,766      
Issuance of common stock from at the market offering, net of issuance costs 41 305     41 305  
Stock-based compensation expense 1,793       1,793    
Net loss (17,982)           (17,982)
Stockholders' equity, ending balance (in shares) at Jun. 30, 2025     45,335,265        
Stockholders' equity, ending balance at Jun. 30, 2025 41,464   $ 5   492,118   (450,659)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock from at the market offering, net of issuance costs (in shares)       1,938,420      
Issuance of common stock from at the market offering, net of issuance costs   $ 3,287       $ 3,287  
Stock-based compensation expense $ 1,233       1,233    
Stock option exercises (in shares) 0            
Net loss $ (16,370)           (16,370)
Stockholders' equity, ending balance (in shares) at Sep. 30, 2025 47,273,685   47,273,685        
Stockholders' equity, ending balance at Sep. 30, 2025 $ 29,614   $ 5   $ 496,638   $ (467,029)